首页> 外文会议>Asian Symposium on biomedical materials >Degradation Control of Collagen by Epigallocatechin-3-O-Gallate
【24h】

Degradation Control of Collagen by Epigallocatechin-3-O-Gallate

机译:Epigallocatechin-3-O-Gallate对胶原蛋白的降解控制

获取原文

摘要

Stabilization of the fibrous protein collagen is important in biomedical applications. This study investigated the efficacy of degradation control of collagen using (-)-epigallocatechin-3-O-gallate (EGCG). EGCG treatment of collagen in solid state was carried out and collagen sponges produced were characterized by measuring the physicochemical properties such as gel fraction, the enzymatic degradability and cytocompatibility. According to gel fraction, EGCG-treated sponges showed the increase of insolubility compared to intact sponges. It showed that EGCG played a role in a crosslinker of collagen. Through in vitro enzymatic degradation test, EGCG-treated collagen sponges showed significant enhancement of resistance to collagenase in comparison with 25 mM EDC-treated collagen sponges. Also, cell proliferation assays showed that 40 mM EGCG-treated collagen sponges exhibited similar cytocompatibility properties compared with tissue culture plate. In summary, EGCG treatment of collagen sponges increased the stability of collagen. Therefore, crosslinking of collagen based scaffold with EGCG imparted more desirable properties, making it more applicable for use as a scaffold in tissue engineering applications.
机译:纤维蛋白胶原蛋白的稳定化在生物医学应用中是重要的。本研究调查了使用( - ) - EPIGALLOCATECHIN-3-O-Graphate(EGCG)降解胶原蛋白的降解控制的疗效。进行固态中胶原蛋白的EGCG处理,并通过测量诸如凝胶级分,酶促降解性和细胞相容性的物理化学性质来表征产生的胶原海绵。根据凝胶级分,与完整的海绵相比,EGCG处理的海绵显示出不溶性的增加。结果表明,EGCG在胶原蛋白的交联剂中发挥了作用。通过体外酶促降解试验,与25mM EDC处理的胶原海绵相比,EGCG处理的胶原海绵对胶原酶的抗性显着提高。此外,细胞增殖测定表明,与组织培养板相比,40mM EGCG处理的胶原海绵表现出类似的细胞组合性能。总之,EGCG治疗胶原蛋白海绵增加了胶原蛋白的稳定性。因此,基于EGCG的基于胶原的支架的交联赋予了更理想的性质,使其更适用于在组织工程应用中的支架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号